# Arbutus Biopharma Corp: Form DEF 14A, filed Apr 8, 2021

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: DEF 14A
- Filed: 2021-04-08
- Accepted by EDGAR: Apr 8, 2021, 14:52 ET
- Period: 2021-05-26
- Accession: 0001104659-21-047991
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000110465921047991/tm212510-1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000110465921047991/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000110465921047991/tm212510-1_def14a.htm

Filed Apr 8, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-047991. Last ingested by Listed: Nov 10, 2026, 16:58 ET. No prices; not investment advice.